The tretinoin (34) or retinoic acid is able to improve therapeutic efficacy when combined with antibiotic application for treating tuberculosis through regulating MEK/ERK (methyl ethyl ketone/extracellular regulated protein kinases) and p38 MAPK pathway [92]. The gene discussed is MAP2K7; the disease is tuberculosis.